Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Enfusion Inc.

    NYSE: ENFN · Real-Time Price · USD
    10.76
    -0.04 (-0.37%)
    At close: Apr 17, 2025, 3:59 PM

    Enfusion Statistics

    Share Statistics

    Enfusion has 94.8M shares outstanding. The number of shares has increased by 3.15% in one year.

    Shares Outstanding

    n/a
    		 94.8M

    Shares Change (YoY)

    n/a
    		 3.15%

    Shares Change (QoQ)

    n/a
    		 0.46%

    Owned by Institutions (%)

    n/a
    		 98.11%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 331

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 1.3M, so 1.37% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.3M

    Short % of Shares Out

    n/a
    		 1.37%

    Short % of Float

    n/a
    		 2.83%

    Short Ratio (days to cover)

    n/a
    		 1.57

    Valuation Ratios

    The PE ratio is 335.84 and the forward PE ratio is 29.08. Enfusion's PEG ratio is -4.14.

    PE Ratio

    n/a
    		 335.84

    Forward PE

    n/a
    		 29.08

    PS Ratio

    n/a
    		 4.7

    Forward PS

    n/a
    		 3.3

    PB Ratio

    n/a
    		 12.95

    P/FCF Ratio

    n/a
    		 30.54

    PEG Ratio

    n/a
    		 -4.14
    Financial Ratio History

    Enterprise Valuation

    Enfusion has an Enterprise Value (EV) of 913.9M.

    EV / Sales

    n/a
    		 4.53

    EV / EBITDA

    n/a
    		 148.48

    EV / EBIT

    n/a
    		 26.35

    EV / FCF

    n/a
    		 29.44

    Financial Position

    The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.28.

    Current Ratio

    n/a
    		 3.42

    Quick Ratio

    n/a
    		 3.42

    Debt / Equity

    n/a
    		 0.28

    Debt / EBITDA

    n/a
    		 3.3

    Debt / FCF

    n/a
    		 0.65

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 3.86% and Return on Invested Capital is 1.93%.

    Return on Equity

    n/a
    		 3.86%

    Return on Assets

    n/a
    		 1.97%

    Return on Invested Capital

    n/a
    		 1.93%

    Revenue Per Employee

    n/a
    		 $176,387.58

    Profits Per Employee

    n/a
    		 $2,469.82

    Employee Count

    n/a
    		 1,143

    Asset Turnover

    n/a
    		 1.41

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 4.57M

    Effective Tax Rate

    n/a
    		 61.79%

    Stock Price Statistics

    The stock price has increased by 14.23% in the last 52 weeks. The beta is 0.93, so Enfusion's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.93

    52-Week Price Change

    n/a
    		 14.23%

    50-Day Moving Average

    n/a
    		 11.1

    200-Day Moving Average

    n/a
    		 9.83

    Relative Strength Index (RSI)

    n/a
    		 42.68

    Average Volume (20 Days)

    n/a
    		 1,164,473

    Income Statement

    In the last 12 months, Enfusion had revenue of 201.61M and earned 2.82M in profits. Earnings per share was 0.02.

    Revenue

    n/a
    		 201.61M

    Gross Profit

    n/a
    		 136.74M

    Operating Income

    n/a
    		 6.16M

    Net Income

    n/a
    		 2.82M

    EBITDA

    n/a
    		 6.16M

    EBIT

    n/a
    		 6.16M

    Earnings Per Share (EPS)

    n/a
    		 0.02
    Full Income Statement

    Balance Sheet

    The company has 54.48M in cash and 20.31M in debt, giving a net cash position of 34.17M.

    Cash & Cash Equivalents

    n/a
    		 54.48M

    Total Debt

    n/a
    		 20.31M

    Net Cash

    n/a
    		 34.17M

    Retained Earnings

    n/a
    		 -170.11M

    Total Assets

    n/a
    		 143.26M

    Working Capital

    n/a
    		 66.19M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 34.68M and capital expenditures -3.63M, giving a free cash flow of 31.05M.

    Operating Cash Flow

    n/a
    		 34.68M

    Capital Expenditures

    n/a
    		 -3.63M

    Free Cash Flow

    n/a
    		 31.05M

    FCF Per Share

    n/a
    		 0.34
    Full Cash Flow Statement

    Margins

    Gross margin is 67.82%, with operating and profit margins of 3.05% and 1.4%.

    Gross Margin

    n/a
    		 67.82%

    Operating Margin

    n/a
    		 3.05%

    Pretax Margin

    n/a
    		 3.66%

    Profit Margin

    n/a
    		 1.4%

    EBITDA Margin

    n/a
    		 3.05%

    EBIT Margin

    n/a
    		 3.05%

    FCF Margin

    n/a
    		 15.4%

    Dividends & Yields

    ENFN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.3%

    FCF Yield

    n/a
    		 3.27%
    Dividend Details

    Analyst Forecast

    The average price target for ENFN is $12.25, which is 13.8% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $12.25

    Price Target Difference

    n/a
    		 13.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 14.44

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist